Heyholder
‹ Activism Filings

WOOREE BIO CO., LTD Q3 revenue KRW 350.2 billion, operating loss of KRW 5.1 billion, turning to a loss

WOOREE BIO CO., LTD· Periodic Report

AI summary · Not investment advice

Woori Bio sold KRW 350.2 billion worth in Q3 but lost KRW 5.1 billion from its main business, turning from a profit a year earlier to a loss.

Operating profit · 3 months

KRW -5.1 billion

Key facts

Revenue (3 months)
KRW 350.2 billion
Net income (3 months)
KRW -18.4 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (prior-year 3 months)
KRW 263.9 billion
Revenue (year to date)
KRW 935.8 billion
Operating profit (prior-year 3 months)
KRW 2.4 billion
Operating profit (year to date)
KRW -11.9 billion
Net income (prior-year 3 months)
KRW 2.7 billion
Net income (year to date)
KRW -20.8 billion

Commentary

AI commentary · Not investment advice

What happened

Woori Bio reported its 3rd-quarter results on a consolidated basis. Sales for the latest 3 months were KRW 350.2 billion. That is 32.7% higher than the same 3 months a year earlier (KRW 263.9 billion). It is also 10.7% higher than the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was a loss of KRW 5.1 billion. A year earlier, the company made a profit of KRW 2.4 billion. It has now turned to a loss.

What changes for shareholders

Net income (the final profit after taxes and all other costs) for the 3 months was a loss of KRW 18.4 billion. A year earlier, it was a profit of KRW 2.7 billion. This also turned to a loss.

For the year so far (January 1 to September 30), sales were KRW 935.8 billion. Operating profit was a loss of KRW 11.9 billion. Net income was a loss of KRW 20.8 billion.

Comments

No comments yet

Comments from shareholders will appear here.